|
WO03063573A2
|
|
Method for treating diseases with omega interferon
|
|
IL155730D0
|
|
Method for short-term and long-term drug dosimetry
|
|
CA2424299A1
|
|
Combination therapy for the treatment of estrogen-sensitive disease
|
|
US6673370B2
|
|
Oxidized collagen formulations for use with non-compatible pharmaceutical agents
|
|
AU2985801A
|
|
Use of cell membrane permeants in the treatment of cellular proliferative diseases
|
|
ZA200101048B
|
|
Method of mitigating the adverse effects of Interleukin-2.
|
|
US6566395B1
|
|
Methods of treating proliferative disorders
|
|
AU5683199A
|
|
Method of mitigating the adverse effects of interleukin-2
|
|
US6630168B1
|
|
Gel delivery vehicles for anticellular proliferative agents
|
